ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Rapamycin (RPM) Synergizes with CD154 mAb and DST to Promote Long-Term Vascularized Composite Allograft (VCA) Survival, but Prevents Induction of Donor-Specific Tolerance.

L. Wang, Z. Wang, R. Han, T. Bhatti, L. Levin, M. Levine, W. Hancock.

CHOP & UPenn, Philadelphia.

Meeting: 2016 American Transplant Congress

Abstract number: A94

Keywords: Effector mechanisms, Graft acceptance, Lymphocyte activation, Tissue-specific

Session Information

Date: Saturday, June 11, 2016

Session Name: Poster Session A: Clinical Vascularized Composite Allotransplantation

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Related Abstracts
  • Clinically Relevant Anti-TCR mAb Induction Plus Brief Rapamycin Therapy Can Achieve Long-Term Vascularized Composite Allograft (VCA) Survival
  • Pre-Transplant Infusion of Extracorporeal Photopheresis Treated Donor Splenocytes Leads to Long-Term Liver Allograft Survival and Donor Specific Tolerance in Rats.

Even though CD154 mAb (MR-1) plus donor splenocyte transfusion (DST) is very effective at inducing tolerance of various allografts, such as those of hearts, kidneys or islets in mice, using fully MHC-disparate combinations such as BALB/c->C57BL/6, it was ineffective at prolonging corresponding hindlimb VCA survival. However, after RPM was added to the peri-transplant therapeutic protocol, long-term VCA survival was achieved (>100 days, p<0.01). We tested whether this long-term graft survival was donor specific tolerance or not by challenging recipients with third party (C3H) cardiac allografts. Surprisingly, long-surviving VCA recipients did not reject the third-party cardiac allografts, but instead rejected the original VCA tissues. Analysis of blood samples within the early post-Tx period showed almost equal effectiveness of CD154/DST and CD154/DST/RPM protocols at inhibiting T cell alloresponses, with the exception that T cell proliferation (Ki-67+) was higher in recipients that did not receive RPM therapy. To test whether RPM impaired tolerance induction by CD154/DST to non-VCA samples, we transplanted BALB/c cardiac allografts into C57BL/6 recipients and treated the recipients with either CD154/DST alone, or with RPM. One month later, the recipients were challenged with third party (C3H) hearts. As anticipated, recipients treated with CD154/DST rejected the third-party C3H allografts but maintained their original BALB/c allografts. However, recipients treated with CD154/DST plus RPM did not reject their third-party allografts or their original cardiac allografts. Hence, RPM erases the fundamental tolerogenicity of CD154/DST therapy. In the case of VCA, peri-transplant RPM therapy dampened immune function to a useful extent, facilitating long-term VCA survival, but the rejection of VCA tissues as a result of third party cardiac allografting suggests the incomplete regulation of host alloresponses by Treg or other cells in the face of ongoing expression of skin-associated antigens (and is consistent with some clinical VCA data). We have previously shown that calcineurin inhibitor therapy completely abrogates the benefits of CD154/DST in allograft models. Taken together with the current data, immunosuppressive agents may be able to promote VCA long-term survival but cannot induce tolerance, and host alloresponses are decreased but by no means absent long-term.

CITATION INFORMATION: Wang L, Wang Z, Han R, Bhatti T, Levin L, Levine M, Hancock W. Rapamycin (RPM) Synergizes with CD154 mAb and DST to Promote Long-Term Vascularized Composite Allograft (VCA) Survival, but Prevents Induction of Donor-Specific Tolerance. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Wang L, Wang Z, Han R, Bhatti T, Levin L, Levine M, Hancock W. Rapamycin (RPM) Synergizes with CD154 mAb and DST to Promote Long-Term Vascularized Composite Allograft (VCA) Survival, but Prevents Induction of Donor-Specific Tolerance. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/rapamycin-rpm-synergizes-with-cd154-mab-and-dst-to-promote-long-term-vascularized-composite-allograft-vca-survival-but-prevents-induction-of-donor-specific-tolerance/. Accessed February 26, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.